| Code |
| INAF |
| Title |
| PT. Indofarma Tbk |
| Address |
| Head Office | : | | | Address | : | Jl. Indofarma No. 1 Cikarang Barat | | | Bekasi 17530 - Jawa Barat | | Phone | : | (021) 8832 3971/75; (021) 8590 8349/50 | | Fax | : | (021) 8832.3972 - 73; (021) 857 4503 | | E-mail | : | corsec@indofarma.id; headoffice@indofarma.id | | Website | : | www.indofarma.id | | Commercial Office | : | | | | Plaza Bank Bumi Daya, 12Ath & 14th Floor | | | Jl. Imam Bonjol No.61 - Jakarta | | Phone | : | (021) 3983 4030 | | Fax | : | (021) 3983 4031 | | E-mail | : | | | Website | : | |
|
| Background |
The Company engage activities :a. Producing pharmaceutical raw and indirect materials, and chemical materials including agrochemical by itself or under license or contract with other partiesb. Producing of finished goods such as essential medicine, generic medicine, branded medicine, traditional medicine, cosmetics, medical devices, diagnostics and contraceptives. The Company also produces food products or any those related with health care and health improvement including animal food products. The Company produces such goods by itself or under license or contract with other parties.c. Producing packaging materials, machinery and equipment and infrastructure related to pharmaceutical industry or other industries. |
| Business cp product |
The Company engage activities :a. Producing pharmaceutical raw and indirect materials, and chemical materials including agrochemical by itself or under license or contract with other partiesb. Producing of finished goods such as essential medicine, generic medicine, branded medicine, traditional medicine, cosmetics, medical devices, diagnostics and contraceptives. The Company also produces food products or any those related with health care and health improvement including animal food products. The Company produces such goods by itself or under license or contract with other parties.c. Producing packaging materials, machinery and equipment and infrastructure related to pharmaceutical industry or other industries. |
| Subsidiary affiliation |
| Subsidiaries | Domicile | Business | % | | PT Indofarma Global Medika | Jakarta | Distribution and trading of pharmaceutical products | 99.99 |
|
| Commissioners |
| President Commissioner | : Laksono Trisnantoro | | | Commissioner | Didi Agus Mintadi | | | Independent Commissioner | : Teddy Wibisana | | | Independent Commissioner | : Achmad Ghufron Sirodj | | | | | | Per 30 Sep 2023 | | |
|
| Directors |
| President Director | : Agus Heru Darjono | | | Director | : Ariesta Kurniawan | | | Director | Jejen Nugraha | | | Director | : Kamelia Faisal | | | | | | Per 30 Sep 2023 | | |
|
| Underwriter |
| PT. Bahana Securities (Representative - Affiliated) | | | PT. Bhakti Capital Indonesia | | | PT. Trimegah Securities | | | Amantara Securities, Andalan Artha Advisindo Sec., Bali Sec., Bapindo Bumi Sekuritas (Affiliated) | | | BNI Securities | | | |
| Share registrar |
|
| Share holders |
| Shareholders | Shares | % | | | | | | | | | - PT Bio Farma (Persero) | 2499999999 | 80.66 | | | | - PT ASABRI (Persero) | 227533850 | 7.34 | | | | - Negara Republik Indonesia | 1 | 0 | | | | - Public | 371733650 | 11.99 | | | | | | | | | As of Sep 30, 2023 | | | | |
|
| History stocks |
Type of ListingDatePrice## of SharesTotal Listed Shares IPO @Rp. 25017-Mar-20011005968750003096875000 Option Conversion26-Aug-200210023925003099267500
|
| Other infos |
|
| Created date |
| 2023-11-03 14:28:36 |
| Revised date |
| 2023-11-03 14:28:36 |
| Finance |
2023,
2022,
2021,
2020,
2019,
2018,
2017,
2016,
2015,
2014,
2013,
| Financial Statetment Date |
| Fiscal Year Ends |
| Months Covered in Income St |
| |
| Summary Covered in Income St |
| Cash and Cash Equivalents |
| Receivables |
| Inventories |
| Current Assets |
| Fixed Assets |
| Other Assets |
| Non Current Assets |
| Total Assets |
| Current Liabilities |
| Longterm Liabilities |
| Total Liabilities |
| Authorized |
| Paid-up Capital |
| Par Value |
| Paid-up Capital Shares |
| Retained Earnings |
| Total Equity |
| Minority Interest |
| |
| Summary of Income Statement |
| Total Sales |
| Cost of Good Sold |
| Gross Profit |
| Operating Profit |
| Other Income |
| Earning Before Tax |
| Tax |
| Net Income |
| Close Price |
| |
| Per Share Data (Rp) |
| Eps (annualized) |
| Book Value |
| |
| Financial Ratios |
| Debt Equity Ratio (X) |
| Roa(%) |
| Roe(%) |
| Npm(%) |
| Opm(%) |
| Gross Profit Margin (%) |
| Total Assets Turnover |
| |
| Cash Flow |
| CF from Operation Activities |
| CF from Investing Activities |
| CF from Financing Activities |
| Net Increase in Cash & Cash Equivalent |
| Cash & Cash Equivalent at Beginning of the Year |
| Cash & Cash Equivalent at The End of the Year |
|
|